InterMed Group (PRIVATE.INTERMED)

Overall impact
C (44)

Commentary

InterMed Group is an average overall performer. With a 'C' rating of 43.5 for overall impact (30th percentile compared to all companies), InterMed Group ranks 15th out of 21 industry peers, behind JD Health International, Suzuken Co., Palex Medical and 11 others, and ahead of Cardinal Health, Cencora, McKesson and 3 others. On top material causes for InterMed Group's industry (Health Care Equipment & Supplies), InterMed Group performs well in Access to Affordable Healthcare (95.2 score), Child and Maternal Health (95.2), Child and Maternal Health (95.2) and 2 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (15.2 score), Sustainable Use of Natural Resources (15.9), Racial Justice and Civil Rights (17.5) and 7 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.INTERMED
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
146
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Distributors
SASB industry
Healthcare Distributors
Headquarters
#<Country/State:0x00007246b0a84b20>, United States
Share classes
PRIVATE.INTERMED
Description
InterMed Group is a healthcare technology management services provider offering integrated asset and lifecycle management for biomedical and medical imaging equipment — including maintenance and repairs, parts, regulatory-compliance programs, and sales/service of new and pre-owned imaging systems.
Material causes
Ethos considers the following causes material for InterMed Group, based on its industry sub-industry Health Care Distributors. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.